Description

Flenox (enoxaparin sodium) solution for injections 4000ME/0.4 ml. №10 syringe

Ingredients

Active ingredient: Enoxaparin sodium

Dosage

Recommended dosage: The usual dose of Flenox is **4000ME** (40 mg) administered by subcutaneous injection once a day.

Indications

Indicated for: Prevention of blood clots in conditions such as deep vein thrombosis and pulmonary embolism.

Contraindications

Do not use Flenox if:

• You are allergic to enoxaparin sodium or heparin
• You have active major bleeding

Directions

Administration: Administer **subcutaneously**. Do not inject intramuscularly.

Scientific Evidence

Enoxaparin, the active ingredient in Flenox, is a low molecular weight heparin that works by inhibiting the formation of blood clots. Studies have shown that enoxaparin is effective in preventing venous thromboembolism in various clinical settings. Research by Turpie AG et al. demonstrated the efficacy of enoxaparin in reducing the risk of deep vein thrombosis after hip replacement surgery.

Additional Information

Flenox is a widely used anticoagulant with a well-established safety profile. It is commonly prescribed for the prevention of blood clots in patients at risk. The convenience of pre-filled syringes makes it easy to administer, enhancing patient compliance with the prescribed treatment regimen.

Enoxaparin acts by potentiating the inhibition of factor Xa and thrombin by antithrombin. This mechanism of action makes it a valuable agent in the prevention of thromboembolic events. Compared to unfractionated heparin, enoxaparin has a more predictable anticoagulant response and a lower risk of heparin-induced thrombocytopenia.